Imunon (IMNN) to Release Quarterly Earnings on Thursday

Imunon (NASDAQ:IMNN - Get Free Report) is set to post its quarterly earnings results before the market opens on Thursday, November 7th. Analysts expect Imunon to post earnings of ($0.37) per share for the quarter.

Imunon (NASDAQ:IMNN - Get Free Report) last released its quarterly earnings data on Wednesday, August 14th. The company reported ($0.51) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.55) by $0.04. On average, analysts expect Imunon to post $-2 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Imunon Trading Up 2.2 %

NASDAQ:IMNN traded up $0.02 during mid-day trading on Friday, hitting $0.95. 81,103 shares of the company's stock were exchanged, compared to its average volume of 1,001,912. Imunon has a fifty-two week low of $0.48 and a fifty-two week high of $3.65. The company has a 50 day simple moving average of $1.04 and a 200-day simple moving average of $1.21. The firm has a market capitalization of $57.05 million, a P/E ratio of -0.49 and a beta of 2.13.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on IMNN. EF Hutton Acquisition Co. I upgraded shares of Imunon to a "strong-buy" rating in a research report on Monday, September 23rd. HC Wainwright reiterated a "buy" rating and set a $14.00 price target on shares of Imunon in a report on Thursday, August 15th.

About Imunon

Imunon, Inc, a clinical-stage biotechnology company, engages in the development of immunotherapies and vaccines to treat cancer and infectious diseases. The company's lead clinical program IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development.